The identification of the high-risk patient in Rhesus sensitization by the use of post-partium foetal cell counts.
D000017:ABO Blood-Group System; D000022:Abortion, Spontaneous; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002585:Cesarean Section; D036861:Delivery, Obstetric; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005113:Extraction, Obstetrical; D005260:Female; D005331:Fetomaternal Transfusion; D005333:Fetus; D006470:Hemorrhage / Q000453:epidemiology; D006801:Humans; D007751:Labor, Induced; D007743:Labor, Obstetric; D008431:Maternal-Fetal Exchange; D008875:Middle Aged; D010121:Oxytocin / Q000627:therapeutic use; D010298:Parity; D010920:Placenta / Q000502:physiology; D049590:Postpartum Period; D011247:Pregnancy; D011248:Pregnancy Complications; D011272:Pregnancy, Multiple; D011795:Surveys and Questionnaires; D005719:gamma-Globulins / Q000627:therapeutic use
D000017:ABO Blood-Group System; D005719:gamma-Globulins; D010121:Oxytocin